Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis

  • Authors:
    • Min Chen
    • Jian Wu
    • Xing‑Xing Zhang
    • Qiong Wang
    • Shi‑Hai Yan
    • Hai‑Dan Wang
    • Sheng‑Lin Liu
    • Xi Zou
  • View Affiliations

  • Published online on: November 21, 2016     https://doi.org/10.3892/ol.2016.5404
  • Pages: 370-376
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Sesquiterpenoids are a major type of compound found in Solanum lyratum (S. lyratum). The present study aimed to investigate whether sesquiterpenoids from S. lyratum demonstrated cytotoxicity against the MCF-7, HCT-8, A-549, SGC-7901 and BEL-7402 cell lines, and the mechanism of solajiangxin H and lyratol D, which exhibited high cytotoxicity against SGC-7901 cells (half maximal inhibitory concentration, IC50=4.8 and 5.9 µg/ml), was associated with mitochondria-mediated apoptosis. The results of the Cell Counting Kit-8 assay indicated that 15 sesquiterpenoids had cytotoxicity against the aforementioned cultured cells. The results of DAPI staining and western blot analysis, used to study the anticancer mechanisms of solajiangxin H and lyratol D in SGC-7901 cells, suggested that solajiangxin H and lyratol D induced the apoptosis of SGC-7901 cells significantly (P<0.01), downregulated the expression of the antiapoptotic proteins B‑cell lymphoma (Bcl)-2 and survivin, and upregulated the expression of the proapoptotic proteins Bcl-2-like protein 4, second mitochondria-derived activator of caspase, cleaved (c)-caspase-3 and c-caspase-9. The present study therefore demonstrated that 15 sesquiterpenoids from S. lyratum exhibited anticancer activity in MCF-7, HCT-8, A-549, SGC-7901 and BEL-7402 cells, and that the anticancer mechanisms of solajiangxin H and lyratol D may be associated with mitochondria-mediated apoptosis. Additionally, the present study provides evidence in support of the hypothesis that S. lyratum may be a promising candidate for the development of novel cancer therapies.
View Figures
View References

Related Articles

Journal Cover

January-2017
Volume 13 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen M, Wu J, Zhang XX, Wang Q, Yan SH, Wang HD, Liu SL and Zou X: Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis. Oncol Lett 13: 370-376, 2017.
APA
Chen, M., Wu, J., Zhang, X., Wang, Q., Yan, S., Wang, H. ... Zou, X. (2017). Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis. Oncology Letters, 13, 370-376. https://doi.org/10.3892/ol.2016.5404
MLA
Chen, M., Wu, J., Zhang, X., Wang, Q., Yan, S., Wang, H., Liu, S., Zou, X."Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis". Oncology Letters 13.1 (2017): 370-376.
Chicago
Chen, M., Wu, J., Zhang, X., Wang, Q., Yan, S., Wang, H., Liu, S., Zou, X."Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis". Oncology Letters 13, no. 1 (2017): 370-376. https://doi.org/10.3892/ol.2016.5404